RxDoctor Payments Data

Abner Gershon, MD

Diagnostic Radiology · Farmington, CTNPI 1114922812

Payments from drug & device makers

What this record shows

Penumbra, Inc. accounts for 80.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $540 and has fallen 95.9% since, to $22 in 2024.

$632in general payments, 2019–2025

Across 7 payments — averaging $90.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$511
  • Abbott$53
  • Angiodynamics, Inc.$26
  • Biogen$22
  • Terumo Medical Corporation$21
$110,054in research payments, 2019–2025

Across 5 payments — averaging $22,011 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Guerbet LLC$110K

What the payments were for

  • Travel & lodging$27543%
  • Food & beverage$35757%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$632 in reported general payments places this provider in the 80th percentile of 491 diagnostic radiology providers in Connecticut.

See all diagnostic radiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$62,091
Medicare patients
570
Services billed
859

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Farmington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →